Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 10, 2018 - Issue
Submit an article Journal homepage
79
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis

Ahmed Shelbaya1 Pfizer Inc., New York, NY;2 Columbia School of Public Health, New York, NY
,
Caitlyn T Solem3 Pharmerit International, Bethesda, MD, USACorrespondence[email protected]
,
Chris Walker4 Pfizer Ltd., Tadworth, Surrey, UK
,
Yin Wan3 Pharmerit International, Bethesda, MD, USA
,
Courtney Johnson3 Pharmerit International, Bethesda, MD, USA
&
Joseph C Cappelleri1 Pfizer Inc., New York, NY
Pages 213-222 | Published online: 06 Apr 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.